<?xml version="1.0" encoding="UTF-8"?>
<p>Since the golden era of penicillin, antibiotics have become a staple conventional medicine and have reduced the fatality rate by saving millions of lives, as was proven in World War II [
 <xref rid="B21-microorganisms-08-01934" ref-type="bibr">21</xref>]. In the 1940s, it was the first prescribed antibiotic utilized in the treatment of life-threatening infections. Shortly afterward, the development of antibiotic resistance, and particularly the detection of multiple antibiotic-resistant (MAR) bacteria, has resulted to downturn reduction of the activity of antibiotics [
 <xref rid="B22-microorganisms-08-01934" ref-type="bibr">22</xref>]. The dramatic increase in microbial resistance reduces the efficacy of existing antibiotics and, therefore, negatively affects their applications in human medicine. Over the last century, a number of antibiotics have emerged in the market, and despite this developmental processes, there is evidence of antibiotic resistance being developed against all these antibiotics (
 <xref ref-type="fig" rid="microorganisms-08-01934-f001">Figure 1</xref>) [
 <xref rid="B23-microorganisms-08-01934" ref-type="bibr">23</xref>]. According to the World health Organization (WHO), antibiotic resistance remains one of the leading threats to human health and poses a severe financial burden on healthcare systems worldwide [
 <xref rid="B24-microorganisms-08-01934" ref-type="bibr">24</xref>]. 
</p>
